Physician profile
Travis Kimple
NPI 1114450566
$906.72
in general payments reported to CMS, 2019-2025
11 companies · $21.90 in 2025
The $21.90 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2021: $321 · 2022: $35.04 · 2023: $301 · 2024: $53.10 · 2025: $21.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $243.21 | 2019-2023 | Iaccess Precision Blade, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Alcon Vision LLC | $134.75 | 2019-2023 | Luxor |
| Stryker Corporation | $101.83 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $98.97 | 2021 | |
| Bausch & Lomb Americas INC. | $96.96 | 2023-2025 | Stellaris, Ic-8 Apthera Iol |
| Carl Zeiss Meditec USA, INC. | $78.57 | 2023 | Lumera 700 |
| Allergan, INC. | $55.32 | 2021-2022 | |
| Sight Sciences, INC. | $47.68 | 2021 | |
| Rxsight INC | $28.62 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Abbvie INC. | $13.02 | 2023 | |
| The Cameron-Ehlen Group, INC. | $7.79 | 2023 | Tecnis Iol, Tecnis Simplicity, Healon Pro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Kimple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.